Participant in India’s AstraZeneca Covid-19 vaccine trial sues after experiencing ‘severe adverse effect’

An Indian man who helped

An Indian man who helped test a coronavirus jab based on AstraZeneca’s candidate vaccine has filed suit, claiming that he suffered extreme side effects during his participation in the trial.

The plaintiff, identified in media reports as a 40-year-old man from Chennai, is suing the Pune-based Serum Institute of India (SII) for Rs 5 crore ($676,000 USD). The individual alleges that he suffered serious neurological damage after taking part in the phase three trial of Covishield, the SII’s version of the Covid-19 jab being developed by AstraZeneca and the University of Oxford. The man was purportedly told that the vaccine was safe and chose to participate in the program in “the spirit of public service.”

Continue reading https://on.rt.com/aw2u